Phaseline

Companies › TerSera Therapeutics

TerSera Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 14 registered trials: 7 Phase 2, 4 Phase 3, 2 Phase 1, 1 Phase 4; Metabolic and endocrine, Oncology; next expected readout Mar 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Goserelin
Gonadotropin-releasing hormone receptor agonist
GNRHRPhase 1Advanced Breast Cancer; Musculoskeletal Injury; Prostate Cancer; Breast Cancer …Mar 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05498272GoserelinPhase 2Prostate CancerOncologyDec 2026
NCT00223145GoserelinPhase 3Prostate CancerOncologyDec 2026
NCT02535221GoserelinPhase 3Breast CancerOncologyDec 2026
NCT02476786GoserelinPhase 2Breast CancerOncologyJan 2027
NCT07310420GoserelinPhase 1Advanced Breast CancerOncologyMar 2027
NCT05003752GoserelinPhase 1Prostate AdenocarcinomaOncologyAug 2027
NCT06455969GoserelinPhase 4Musculoskeletal InjuryMetabolic and endocrineAug 2027
NCT06582446GoserelinPhase 2Prostate CancerOncologyAug 2027
NCT06772441GoserelinPhase 2Prostate CancerOncologyOct 2027
NCT01492972GoserelinPhase 3Prostate CancerOncologyDec 2027
NCT07158021GoserelinPhase 2Anatomic Stage I Breast Cancer AJCC v8OncologyJan 2028
NCT02221999GoserelinPhase 2Tubular Breast CancerOncologyJan 2029
NCT04787744GoserelinPhase 2Prostate CancerOncologyMar 2029
NCT05781217GoserelinPhase 3Prostate CancerOncologyDec 2032

Targets

GNRHR (1)

Companies with the same targets

LG Chem JW Pharmaceutical Amgen AbbVie Pfizer Qilu Pharmaceutical Zhuhai Huahaikang Pharmaceutical Technology Kissei Pharmaceutical Changchun GeneScience Pharmaceutical HanAll BioPharma

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.